Exclusive: Era Development in Rehabilitation Medicine and Chinese Strategies

A review of immunomodulatory function of probiotic supplements on human beings

  • CHEN Junfei ,
  • CHEN Jianhao ,
  • CAO Peijiang
Expand
  • 1. Jiangsu Research Institute of Sports Science,Nanjing 210033, China
    2. Department of Sport and Science, Beijing Sport University, Beijing 100084, China

Received date: 2023-03-31

  Revised date: 2023-06-06

  Online published: 2023-12-21

Abstract

This article reviews the functional effects of probiotic supplements on human immune system, the molecular biological mechanisms, and the regulatory effects on relative diseases. Probiotics not only constitute an important part of the local immune system of the intestine but also play a two-way immune regulation role in other systems. probiotic supplements can activate the innate immune system of the human body, improving the activity of phagocyte, natural killer cell and other innate immune cells, which can correct intestinal flora imbalance, prevent digestive tract infection and inflammation caused by virus infection, tumor chemotherapy and radiotherapy, improve the body's immunity to influenza and other upper respiratory tract infections, as well as improve the body's anti-tumor immunity; Probiotic supplements can also negatively regulate the specific immune system through activating regulatory T cells, which plays a certain supportive therapeutic role in treating allergic diseases such as food intolerance and asthma, as well as autoimmune diseases such as ulcerative colitis and Krohn's disease.

Cite this article

CHEN Junfei , CHEN Jianhao , CAO Peijiang . A review of immunomodulatory function of probiotic supplements on human beings[J]. Science & Technology Review, 2023 , 41(23) : 14 -19 . DOI: 10.3981/j.issn.1000-7857.2023.23.002

References

[1] 张灼阳, 刘畅, 郭晓奎 . 益生菌的安全性[J]. 微生物学报, 2008, 48(2): 5.
[2] 洪德轩, 韩政元, 茹懿, 等. 肠道菌群在新冠肺炎中的作用及以肠道菌群为靶标的治疗[J]. 药物生物技术, 2022, 29(4): 419-424.
[3] 徐翰南, 蔡征真, 王云, 等 . 肠道菌群对肠道神经-内分泌-免疫系统的影响及其病理生理意义[J]. 生理学报, 2020, 72(3): 347-360.
[4] Choi V M, Herrou J, Hecht A L, et al. Activation of Bac⁃ teroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice[J]. Nature Medicine, 2016, 22(5): 563-567.
[5] König J, Wells J, Cani P D, et al. Human intestinal barrier function in health and disease[J]. Clinical and Translational Gastroenterology, 2016, 7(10): e196.
[6] Bischoff S C, Barbara G, Buurman W, et al. Intestinal permeability: A new target for disease prevention and therapy[J]. BMC Gastroenterol, 2014, 14: 189.
[7] Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity[J]. PNAS, 2013, 110(22): 9066-9071.
[8] Gleeson M, Bishop N C, Oliveira M, et al. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes[J]. International Journal of Sport Nutrition & Exercise Metabolism, 2011, 21(1): 55-64.
[9] 黄少磊, 邢会霞, 龚虹, 等. 益生菌肽聚糖对机体的免疫刺激作用及其影响因素[J]. 中国微生态学杂志, 2014, 26(5): 604-606.
[10] Cox A J, Pyne D B, Saunders P U, et al. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes[J]. British Journal of Sports Medicine, 2010, 44(4): 222-226.
[11] Michalickova D, Minic R, Dikic N, et al. Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: A randomized, double-blind, placebo-controlled trial[J]. Applied Physiology Nutrition and Metabolism, 2016, 41(7): 782-789.
[12] Salarkia N, Ghadamli L, Zaeri F, et al. Effects of probiotic yogurt on performance, respiratory and digestive systems of young adult female endurance swimmers: A randomized controlled trial[J]. Medical Journal of the Islamic Republic of Iran, 2013, 27(3): 141-146.
[13] Berggren A, Lazou Ahrén I, Larsson N, et al. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections[J]. European Journal of Clinical Nutrition, 2011, 50(3): 203-210.
[14] Lazou Ahrén I, Berggren A, Teixeira C, et al. Evaluatio of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700∶2 on aspects of common cold infections in children attending day care: A randomised, double-blind, placebo-controlled clinical study [J]. European Journal of Clinical Nutrition, 2020, 59(1): 409-417.
[15] 唐曼玉, 王晚晴, 强敬雯, 等. 益生菌与肠道菌群, 免疫调节的相互作用与机制研究进展[J]. 食品工业科技, 2022, 43(16): 8.
[16] 赵琦韬, 沈续航, 沈继龙, 等 . 新冠肺炎患者肠道菌群变化的研究进展[J]. 中国病原生物学杂志, 2021(12): 1480-1484.
[17] Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction[J]. Journal of Immunology, 1997, 159(4): 1739-1745.
[18] Gorissen D M W, Rutten N B M M, Oostermeijer C M J, et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study[J]. Clinical & Experimental Allergy, 2014, 44(11): 1431-1433.
[19] Wei X, Jiang P, Liu J, et al. Association between probiotic supplementation and asthma incidence in infants: A meta-analysis of randomized controlled trials[J]. Journal of Asthma, 2020, 57(2): 167-178.
[20] Borody T J, Khoruts A. Fecal microbiota transplantation and emerging applications[J]. Nature Reviews Gastroenterology & Hepatology, 2011, 9(2): 88-96.
[21] 杨凤英, 鲁鹏, 蓝晓慧, 等 . 益生菌在炎症性肠病治疗中的研究进展[J]. 中国微生态学杂志, 2014, 26(6): 735-739.
[22] 王霄腾, 戴金锋, 吕宾. 益生菌对炎症性肠病诱导和维持缓解疗效的Meta分析[J]. 胃肠病学, 2015, 20(1): 29-35.
[23] Håkansson Å, Andrén Aronsson C, Brundin C, et al. Effects of lactobacillus plantarum and lactobacillus paracasei on the peripheral immune response in children with celiac disease autoimmunity: A randomized, double-blind, placebo-controlled clinical trial[J]. Nutrients, 2019, 11(8): 1925.
[24] Busch R, Gruenwald J, Dudek S. Randomized, double blind and placebo controlled study using a combination of two probiotic lactobacilli to alleviate symptoms and frequency of common cold[J]. Food & Nutrition Sciences, 2013, 4(11A): 13-20.
[25] 郑建伟, 曹李, 康春博 . T 淋巴细胞亚群在早期三阴性乳腺癌新辅助化疗疗效预测中的应用[J]. 癌症进展, 2019, 17(19): 2309-2313.
[26] 邢玉刚, 戴安伟, 王良花. 晚期恶性肿瘤患者化疗前后外周血 T 淋巴细胞亚群监测及临床意义[J]. 临床医药文献电子杂志, 2018, 5(34): 66-67.
[27] Gopalakrishnan V, Spencer C N, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science, 2018, 359(6371): 97-103.
[28] 张雪莹, 秦环龙 . 肿瘤免疫治疗与肠道菌群关系的研究进展[J]. 上海预防医学, 2019, 31(10): 817-823.
[29] Delaune V, Orci L A, Lacotte S, et al. Fecal microbiota transplantation: A promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response[J]. Expert Opinion on Biological Therapy, 2018, 18(10): 1061-1071.
[30] 梁志, 王继军, 李鹏达, 等 . 口服益生菌对结直肠癌化疗患者免疫力影响的 Meta分析[J]. 现代消化及介入诊疗, 2021, 26(10): 1271-1275.
[31] Panebianco C, Andriulli A, Pazienza V. Pharmacomicrobiomics: Exploiting the drug-microbiota interactions in anticancer therapies[J]. Microbiome, 2018, 6(1): 92.
[32] Hong B Y, Sobue T, Choquette L, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis[J]. Microbiome, 2019, 7(1): 66.
[33] Reis Ferreira M, Andreyev H J N, Mohammed K, et al. Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: A large pilot study of the microbiome in acute and late-radiation enteropathy[J]. Clinical Cancer Reseach, 2019, 25(21): 6487-6500.
[34] Pal S K, Li S M, Wu X, et al. Stool bacteriomic profiling in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor-tyrosine kinase inhibitors[J]. Clinical Cancer Reseach, 2015, 21(23): 5286-5293.
[35] Wang Y, Wiesnoski D H, Helmink B A, et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis[J]. Nature Medicine, 2018, 24(12): 1804-1808.
[36] 瞿丛新 . 双歧杆菌三联活菌胶囊预防乳腺癌患者化疗后肠道菌群失调症的应用研究[J]. 中国微生态学杂志, 2016, 28(6): 704-706.
Outlines

/